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Fredrik Sjövall1,2*, Saori Morota1, Johan Persson3, Magnus J Hansson1,4 and Eskil Elmér1,5Abstract
Introduction: In sepsis, mitochondria have been associated with both initial dysfunction and subsequent
upregulation (biogenesis). However, the evolvement of mitochondrial function in sepsis over time is largely
unknown, and we therefore investigated mitochondrial respiration in peripheral blood immune cells (PBICs) in
sepsis patients during the first week after admission to the intensive care unit (ICU).
Methods: PBICs from 20 patients with severe sepsis or septic shock were analyzed with high-resolution respirometry
3 times after admission to the ICU (within 48 hours, days 3 to 4 and days 6 to 7). Mitochondrial DNA (mtDNA),
cytochrome c (Cyt c), and citrate synthase (CS) were measured as indicators of cellular mitochondrial content.
Results: In intact PBICs with endogenous substrates, a gradual increase in cellular respiration reached 173% of
controls after 1 week (P = 0.001). In permeabilized cells, respiration using substrates of complex I, II, and IV were
significantly increased days 1 to 2, reaching 137%, 130%, and 173% of controls, respectively. In parallel, higher levels of
CS activity, mtDNA, and Cyt c content in PBICs (211%, 243%, and 331% of controls for the respective indicators were
found at days 6 to 7; P < 0.0001). No differences in respiratory capacities were noted between survivors and
nonsurvivors at any of the time points measured.
Conclusions: PBICs from patients with sepsis displayed higher mitochondrial respiratory capacities compared with
controls, due to an increased mitochondrial content, as indicated by increased mitochondrial DNA, protein content, and
enzyme activity. The results argue against mitochondrial respiratory dysfunction in this type of cells in sepsis.Introduction
Sepsis is one of the leading causes of admission to the
intensive care unit (ICU). No definitive treatment exists,
and despite advancement in supportive therapies, mor-
tality is still high. Today, a minority of patients succumb
in the initial phase of acute shock, and rather enters the
ensuing more prolonged phase of intensive care, charac-
terized by multiple organ failure (MOF) and the need
for organ-supportive therapies. Today, the primary cause
of death from sepsis is due to unresolving MOF with
withdrawal of supportive therapies [1,2]. The initial phase of* Correspondence: fredrik.sjovall@med.lu.se
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reproduction in any medium, provided the orsepsis is dominated by the systemic inflammatory response
syndrome (SIRS) [3]. This proinflammatory response will
gradually convert to an antiinflammatory response, denoted
the compensatory antiinflammatory response syndrome
(CARS) [4]. In this latter stage, immune cell function of
all major cell lines, such as dendritic cells, lymphocytes,
and neutrophils, has been suggested to be downregulated,
leading to an immunoparalysis, or anergy, which could
leave the patient more vulnerable to deleterious secondary
infections [5-8].
Mitochondrial dysfunction has been implicated as a causa-
tive mechanism for reduced activity of immune cells in
sepsis. Several investigations have demonstrated reduced
function of different aspects of mitochondrial respiratory
activity of peripheral blood immune cells (PBICs) in the
early disease stages of sepsis patients admitted to the ICULtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ably reflecting differences in study population, experimental
setup, and what mitochondria-specific markers have been
chosen for normalization of respiration to cellular content
of mitochondria. The evolution of mitochondrial respira-
tory function in PBICs in the later stages of sepsis is still
largely unknown. Also, it is clear from several studies that
sepsis induces a biogenesis response in which mito-
chondrial mass, number, and/or function increases after
the initial phase of the septic event [12-14].
As PBICs play a central role in the septic syndrome
and with the obvious dynamic changes occurring in the
course of sepsis, we were interested in exploring the evo-
lution of mitochondrial respiratory function in human
PBICs and its relation to outcome.
The specific aims of the present study were to investigate
PBIC mitochondrial respiration, by using high-resolution
respirometry, during the first week of sepsis and to evalu-
ate the response in relation to three different markers of
mitochondrial content. Also, we evaluated whether mito-




The study was approved by the scientific ethical committee
of Copenhagen County, Denmark (H-C-2008-023), and the
regional ethical review board of Lund, Sweden (113/2008,
79/2011, 89/2011). Patients were recruited from the in-
tensive care units (ICUs) of Lund University Hospital and
Copenhagen University Hospital, Rigshospitalet. Written,
informed consent was obtained from the patient or next
of kin. In Denmark, consent from the patient’s primary
health care physician was also required if the patient
was not able to consent. The diagnosis of sepsis was
established by definitions previously described [3], and
severe sepsis was defined as sepsis complicated with at
least one organ failure, defined as sequential organ failure
score (SOFA) ≥2. Septic shock was defined as circula-
tory failure requiring inotropic support to maintain a
systolic blood pressure >90 mm Hg or mean arterial
pressure >65 mm Hg, after adequate fluid resuscitation.
Patients were included within 48 hours after their ad-
mission to the ICU. For patients transferred from other
hospitals, the diagnosis of sepsis should not have been
made more than 24 hours before ICU admission. Pa-
tients with known mitochondrial disease, hematologic
malignancy, or who were pregnant were excluded. Blood
samples were taken at three different time points during
the first week after admission to the ICU: within the
first 48 hours (days 1 to 2), at days 3 to 4, and at days 6 to
7. Thirty-one healthy individuals served as controls, from
whom blood samples were taken after written and in-
formed consent was acquired.Sample preparation
In patients, a maximal volume of 40 ml of blood was
drawn from an existing arterial line in K2EDTA tubes
(Vacuette®, Greiner Bio-One GmbH, Kremmünster, Austria).
In controls, blood samples were taken via venous punc-
ture in K2EDTA tubes. PBICs were isolated from whole
blood by Ficoll gradient centrifugation [15]. After wash-
ing in normal saline, cells were resuspended in 200 to
400 μl of saline, depending on yield, together with 50 to
100 μl of the subject’s own plasma. Final concentration
was determined in a Swelab Alfa hematology analyzer
(Boule Medical AB, Stockholm, Sweden). Median cell count
after preparation was 100 × 106 cells/ml (range, 15 to 280).
Respirometric measurements were performed within 5 hours
of sampling. The analyzed contents from the respirometry
chamber were stored frozen until further use.
High-resolution respirometry
PBICs were placed in the 2-ml oxygraph chamber at a
final concentration of 2.5 to 5 × 106 cells/ml. In intact
cells, respiration media consisted of the subject’s own
plasma, and for permeabilized cells, a respiration media
containing sucrose, 110 mM; HEPES, 20 mM; taurine,
20 mM; K-lactobionate, 60 mM; MgCl2, 3 mM; KH2PO4,
10 mM; EGTA, 0.5 mM; BSA, 1 g/L; pH 7.1 (MiR05) [16].
Measurements were performed at a constant temperature
of 37°C in a high-resolution oxygraph (Oxygraph-2k;
Oroboros Instruments, Innsbruck, Austria). Oxygen con-
centration (micromolar) and oxygen flux (negative time
derivative of oxygen concentration; pmol O2 × s
-1 × 10-6
cells) was recorded with DatLab software 4.3 (Oroboros
Instruments, Innsbruck, Austria). All experiments were
performed at an oxygen concentration >50 μM O2. Cali-
bration at air saturation was performed each day. Instru-
mental background was measured in a separate set of
experiments and automatically corrected for in the ensuing
experiments, according to the manufacturer’s instructions.
Oxygen concentration was automatically calculated from
barometric pressure and solubility factors that were set to
1.0 for water, 0.92 for MiR05, and 0.89 for plasma [17].
Two different protocols were used, one in intact cells
and one in permeabilized cells [13,18]. In intact cells,
respiration is maintained by endogenous plasma-derived
substrates only. Intact cells were suspended in the subject’s
own plasma and were allowed to stabilize at so-called rou-
tine respiration. Oligomycin (1 μg/ml) was then added
to induce a state 4-like respiration (LEAK or State 4o)
in which respiration is primarily related to leakage of
protons over the inner mitochondrial membrane. Max-
imal oxygen flux (as supported by plasma-derived sub-
strates) was subsequently obtained by stepwise (20 to
40 μM) titration of the uncoupler FCCP. Finally, com-
plex I and complex III were inhibited by adding rote-
none (2 μM) and subsequently antimycin-A (1 μg/ml).
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subtracted from the steady-state respiration values.
The second protocol was performed in permeabilized
cells. After cells had stabilized at routine respiration, the
plasma cell membrane was permeabilized by adding dig-
itonin (6 μg/1 × 106 cells; the optimal concentration of
digitonin was evaluated in a different set of experiments;
data not shown). Simultaneously, the complex I substrates
malate and pyruvate (5 mM, respectively) were added.
The ensuing addition of excess ADP (1 mM) stimulated
respiration and represents maximal oxidative phosphor-
ylation capacity (OXPHOS or State 3) for that specific,
NADH-linked, substrate combination. With the subsequent
addition of glutamate (5 mM), pyruvate dehydrogenase
is bypassed, and maximal NADH-linked complex I respir-
ation, OXPHOSCI, was obtained. The subsequent addition
of succinate (10 mM) stimulated respiration further be-
cause of convergent input of electrons through both com-
plex I and complex II via the Q-junction, OXPHOSCI+II.
After maximal OXPHOSCI+II capacity, ATP-synthase was
inhibited by oligomycin (1 μg/ml) to evaluate LEAKCI+II
(State 4o). Maximal electron transportation through res-
piration without oxidative phosphorylation, ETSCI+II, was
evaluated by stepwise (2 to 4 μM) titration of FCCP.
Uncoupled complex II-linked respiration, ETSCII, was
evaluated by adding rotenone, and subsequently, the
ETS was inhibited by antimycin-A. At this point, reoxy-
genation of the oxygraph chamber was performed to a level
of 160 to 180 μM O2. The activity of complex IV was
evaluated by adding N,N,N’,N’-tert-methyl-p-phenyldiamine
(TMPD 0.5 mM), an electron donor to complex IV. Be-
cause of the high level of autoxidation of TMPD, sodium
azide (10 mM), an inhibitor of complex IV, was added and
the difference between the two levels obtained was calcu-
lated as the specific complex IV activity. Control ratios
were derived from maximal FCCP-stimulated respir-
ation or maximal oxidative respiration divided by LEAK
respiration.Analysis of mitochondrial DNA
Mitochondrial DNA (mtDNA) was measured, as previ-
ously described [19], with certain modifications. Frozen
samples (oxygraph chamber content after respiration mea-
surements in MiR05) were thawed, sonicated, and subse-
quently diluted 500 times in a buffer containing 10 mM
Tris-HCl, 1 mM EDTA, salmon sperm DNA, 1 ng/μl, pH
8.0. Ten microliters of this dilution were amplified in
a 25-μl PCR reaction containing 1 × Power SYBRW
Green PCR Master Mix by using a StepOnePlus™ Real-
Time PCR System (Applied Biosystems Inc., Foster City,
CA, USA) and 100 nM of each primer (Eurofins MWG
Operon, GmbH, Ebersberg, Germany). The primers
targeted the human mitochondrial COX-1 gene (forward:CCC CTG CCA TAA CCC AAT ACC A, reverse: CCA
GCA GCT AGG ACT GGG AGA GA). The threshold
cycle (Ct) values were related to a standard curve by using
cloned PCR products (kindly provided by P. Schjerling,
University of Copenhagen, Denmark). Samples were an-
alyzed in duplicate.
Cytochrome c determination
Human cytochrome c (Cyt c) content was quantified by
using an immunoassay kit (DCTC0, Quantikine®, R&D
Systems, Abingdon, UK). Frozen samples (same as de-
scribed earlier) were thawed and sonicated and subsequently
processed according to the manufacturer’s instructions.
Citrate synthase determination
A commercially available kit (Citrate Synthase Assay Kit,
CS 0720; Sigma), was used according to manufacturer’s in-
structions, to determine citrate synthase (CS) activity in the
frozen samples. Data are expressed as arbitrary units (a.u.).
Cytokine measurement
The levels of the proinflammatory cytokines tumor necrosis
factor (TNF)-α, IL-1β, and IL-6 were analyzed with a multi-
plex sandwich immunoassay according to the manufac-
turer’s instructions (MSD® 96-well Multi-Spot®; Meso Scale
Discovery, Gaithersburg, MD, USA). In brief, precoated
96-well plates were incubated with plasma samples for
2 hours. Subsequently, detection antibodies were added,
and the plate incubated for another 2 hours. After wash-
ing, the plate was read with MSD Sector Imager®. Because
the variation of the cytokine levels in the healthy controls
was low, the number was restricted to 12 randomly se-
lected subjects.
Data analysis
Statistics were calculated by using Graph Pad Prism v. 5
(GraphPad Software Inc., La Jolla, CA, USA). Data were
tested for normal distribution with the D’Agostino and
Pearson omnibus normality test. Data are presented as
mean ± SD if not indicated otherwise. Analysis between
groups was performed by using the unpaired Student's t
test. Differences between days were analyzed with repeated
measures ANOVA and, when significant, paired Student's t
tests between days were performed. The results were
adjusted with Bonferroni correction for multiple tests.
Correlations were performed by using linear regression. A
P value of <0.05 was considered statistically significant.
Results
We recruited 20 patients with severe sepsis or septic
shock and 31 controls, whose characteristics are presented
in Table 1. The patients included were predominantly
female (13 of 20) with a median age of 70 years (IQR, 62
to 74.5 years). The primary sites of infection were soft
Table 1 Characteristics of patients and controls
Patients Controls
Age, years 70 (62–75) 31 (23–59)
Sex, female/male 13/7 15/16
SAPS II 50 (38–61)






Severe sepsis/septic shock 1/19
Outcome
28-day mortality (%) 6 (30)
90-day mortality (%) 7 (35)
Data presented as median (IQR) or absolute values. SAPS, Simplified Acute
Physiologic Score; APACHE, Acute Physiology and Chronic Health
Evaluation score.
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of 20), and urinary tract (one of 20). Table 2 shows
clinical characteristics of the sepsis patients during the
first week in the ICU. Five patients (25%) died, and an-
other five patients were discharged or transferred to other
facilities within the first week leaving the patient cohort
at days 3 to 4 with n = 15 and n = 10 at days 6 to 7. Nor-
adrenaline was the preferred inotropic drug, with dobuta-
mine added in some cases.
Cellular respiration in septic patients
In the first protocol using intact cells analyzed in the
patient’s own plasma, routine respiration but not max-
imal stimulated respiration with FCCP was significantly
increased within the first 48 hours of admission (3.7 ± 0.6
versus 4.7 ± 1.2, P = 0.04; and 10.4 ± 3.2 versus 12.6 ± 2.5,
P = 0.06; pmol O2 × s
-1 × 10-6 cells, respectively). At
the subsequent time points measured, a gradual increase
in cellular respiration was noted. At day 6 to 7, routine
respiration had increased to 6.4 ± 2.1 pmol O2 × s
-1 × 10-6
cells, P = 0.001; and FCCP-stimulated respiration wasTable 2 Clinical characteristics of patients and controls at tim
Day of sample 1 Day of sa
SOFA 8.0 (6.5-11) 7.0 (3–10
Noradrenaline 0.13 (0.045-0.52) 0.0 (0.0-0.
Dobutamine 4.7 (2.9-9.1) 2.0 (1.0-10
IL-6 259 (112–1433)a 51 (30–80
TNF-α 26 (10–44)a 11 (8.9-20
IL-1β 2.1 (1.2-3.5)a 0.9 (0.6-1.
Data presented as median (IQR). SOFA, Sequential Organ Failure Assessment. Inotro
receiving noradrenaline: sample 1, n = 19; sample 2, n = 6; sample 3, n = 3. Dobuta
compared with controls.16.8 ± 6.5 pmol O2 × s
-1 × 10-6 cells, P = 0.005; Figure 1A.
No difference was found in LEAK respiration between
sepsis patients and controls or during the different time
points measured. Because of the tight coupling of respir-
ation, with LEAK values approaching the residual oxygen
consumption, control ratios could not be calculated.
In permeabilized cells, respiration using substrates
of either complex I, II, or both for OXPHOS and ETS,
as well as substrates of complex IV, all significantly
increased compared with controls at days 1 to 2 (10.5 ±
2.4 versus 7.4 ± 0.9, 7.2 ± 1.9 versus 5.5 ± 1.0, 15.6 ± 3.1
versus 12.0 ± 1.2, 18.8 ± 5.3 versus 9.9 ± 2.6, and 12.0 ±
4.5 versus 7.0 ± 2.9 pmol O2 × s
-1 × 10-6 cells, respect-
ively; P < 0.001 for all comparisons). As with intact
cells, a trend was seen to further increase in respiration in
the sepsis patients between days 1 and 2 and days 6 and 7;
Figure 1B.
Control ratios (CRs) of respiration are calculated as an
internal reference of ATP-generating capacity and the ex-
tent of control the phosphorylating system exerts on the
maximal electron transfer. The control ratios for maximal
OXPHOS (OXPHOSCI+II/LEAK) and ETS (ETSCI+II/LEAK)
were higher in patients as compared with controls (except
for days 3 to 4 OXPHOS). In addition, in patients with
sepsis ETSCI+II/LEAK also increased significantly from the
first to last time point; Figure 1C, D.
Cellular mitochondrial content
The septic syndrome is a dynamic event in many ways.
Clinically, patients go from being severely ill to either
die of the disease or recover. At the cellular level, the
subpopulations of PBICs have been shown to change
phenotypes and undergo apoptosis [8], and, at the mito-
chondrial level, sepsis is known to initiate biogenesis
[20]. Therefore, to be able to put changes in mitochon-
drial respiration into context, we analyzed three different
mitochondrial-specific markers that were subsequently
related to mitochondrial respiration in each sample. CS
and mtDNA correlated well to each other as well as to
respiration (as shown in Figure 2A, B, E), whereas the
correlation for Cyt c were weaker compared both to CSe of blood sampling
mple 2 Day of sample 3 Controls
) 6.5 (4.8-9.8) -
08) 0.0 (0.0-0.09) -
) - -
)a 26 (18–65)a 1.2 (1.0–2.3)
)a 6.7 (5.2-8.7)b 3.7 (2.7-4.2)
3) 0.9 (0.7-1.2) 0.5 (0.2-0.6)
pic drugs are expressed as μg/kg/min, and cytokine levels as pg/ml. Patients







































































































































Figure 1 Cellular mitochondrial respiration. In (A) intact cells and (B) permeabilized cells from healthy controls and sepsis patients at three
different time points. Control ratios for maximal respiration of (C) the oxidative phosphorylation system (OXPHOS) and (D) electron-transfer
system (ETS). Graphs presented as mean ± SD. *P < 0.05 as compared with controls; #P < 0.05 as compared with days 1 to 2. The different
respiratory states are explained in the Methods section.
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Cyt c data in relation to respiration was therefore pursued.
As displayed in Figure 3 all markers of mitochondrial
content increased during the time course studied but
with different kinetics. Cyt c content remained at the
same level as controls during the first two time points
measured in the sepsis patients but significantly increased
by days 6 to 7 (27.4 ± 35 versus 7.6 ± 6.9 ng/ml; P = 0.01).
MtDNA displayed a higher copy count per cell as com-
pared with controls at days 1 to 2 (4,030 ± 1,219 versus
2,381 ± 1,217; P < 0.001), which remained similar at days
3 to 4 (4,124 ± 1,022) with a further increase, at days 6to 7, to 5,418 ± 2,281, compared with controls. CS activity
was also significantly increased as compared with controls
at days 1 to 2 (82 ± 20 versus 44 ± 25 a.u.; P < 0.001)
and remained similar throughout the other time points
(75 ± 24 and 93 ± 29 a.u., respectively).
Respiration related to specific mitochondrial content
CS activity increased relatively more compared with cel-
lular respiration. As a result, mitochondrial respiration,
when expressed in relation to CS, displayed a 27% to
52% reduction in OXPHOSCI+II LEAK and ETSCII re-
spiratory states. Despite similar values, the decrease was














































































































































Figure 2 Correlation between mitochondrial markers. (A) Citrate synthase (CS), (B) mitochondrial DNA (mtDNA), (C) cytochrome c (Cyt c) and
maximal ATP-generating respiration in permeabilized cells (OXPHOSCI+II). Correlation between CS and Cyt c (D) and CS and mtDNA (E).
Correlations were performed by using linear regression.
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at days 1 to 2 and LEAK respiration at all time points.
Maximal ETSCI+II capacity, however, remained unaltered
(Figure 4A). When related to mtDNA, the trends for
OXPHOS and ETSCII were similar (Figure 4B).
However, as shown in Figure 4C and D, the control ra-
tios were not different from those obtained when respir-
ation was expressed per cell. Both OXPHOSCI+II/LEAK
(controls: 6.5, days 1 to 2: 8.0, days 3 to 4: 8.1, days 6 to
7: 8.7) and ETSCI+II/LEAK (controls: 5.5, days 1 to 2; 9.6,








































Figure 3 Levels of mitochondrial markers. (A) Citrate synthase (CS); (B)
samples from controls and patients during the first week of sepsis. Graphs pre
compared with days 1 to 2; a.u., arbitrary unit.increased at all measured time points as compared
with controls.
Respiration related to cytokine levels
Values of the analyzed cytokines, TNF-α, IL-1β, and IL-6,
are given in Table 2. All three were significantly increased
compared with controls at days 1 to 2. IL-1β returned to
similar levels as controls from the second time point,
whereas TNF-α and IL-6 displayed gradually decreasing
levels throughout the week but remained significantly























mitochondrial DNA (mtDNA); (C), cytochrome c (Cyt c) in analyzed











































































































Figure 4 Adjusted mitochondrial respiration. Mitochondrial respiration in permeabilized cells adjusted for (A) citrate synthase activity (CS) and
(B) mitochondrial DNA content (mtDNA). The different respiratory states presented are explained in the Materials and methods section. Control
ratios for maximal respiration of (C), the oxidative phosphorylation system (OXPHOS), and (D) electron-transfer system (ETS) calculated from
mtDNA-adjusted respiration. Presented as mean ± SD. *P < 0.05.
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and mitochondrial respiratory capacity at any of the
time points measured (data not shown).
Alterations in mitochondrial respiration in relation
to mortality
In patients with sepsis, previous reports analyzing
mitochondrial function within the first days after ICU
admission indicated that nonsurvivors have a lower mito-
chondrial respiratory capacity [10] or mRNA expressionof mitochondrial biogenesis factors [12], as compared with
survivors. Our results did not reveal any difference
between 90-day survivors and nonsurvivors, in either
respiratory capacity or markers of mitochondrial con-
tent, as measured at days 1 to 2 (Figure 5A to A - F)
or any other time point (data not shown).
Discussion
The key finding of the present study is that PBICs from


















































































































































Figure 5 Differences between survivors and nonsurvivors. Days 1 to 2 levels of mitochondrial markers (A-C) and mitochondrial respiration
normalized to respective marker, citrate synthase (CS), mitochondrial DNA (mtDNA), and cytochrome c (Cyt c) (D-F) in 90-day survivors and
nonsurvivors. Displayed as box-and-whisker plot (median, IQR and range). Survivors n = 13; nonsurvivors, n = 7; a.u., arbitrary unit.
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controls, in the early phase of the disease that gradually
continued to increase during the course of the first week.
The higher cellular respiratory capacity and respiratory
control ratios seem to stem from an increase in both mito-
chondrial quantity and mitochondrial protein content.
We previously showed an increase in mitochondrial
respiration in human platelets during the first week of
sepsis. This increase was paralleled by a slight increase
in Cyt c content but unaltered mtDNA [13]. Compared
with platelets, PBICs are nuclear-bearing and, as such,
have the ability to transcribe and translate nuclear-encoded
mitochondrial proteins, without relying on whole cell de
novo synthesis. In the present study, PBICs also exhibited
an increase in respiration throughout the first week of
sepsis. Intact PBICs respired primarily by using complex
I-linked substrates, as demonstrated by the almost complete
cessation of respiration after inhibition of complex I by
rotenone (not shown). Also, unaltered LEAK respiration
(oligomycin-induced state 4 respiration) in combination
with the detected increased parameters of maximal
coupled and uncoupled respiration resulted in higher
control ratios, confirming an increased efficacy of the
mitochondria from the sepsis patients as compared with
controls.
In a recent study, the ATP-generating (OXPHOS) cap-
acity of PBICs analyzed with complex II-linked substrates
was reduced in the early phase of sepsis, as compared with
control subjects that constituted critically ill patients
without sepsis. No differences were seen in the otherrespiratory states (that is, routine, LEAK, or non-ATP-
generating respiration (ETS) [10]). In addition, the PBICs
of sepsis patients were, as compared with the controls,
more sensitive to oligomycin-induced inhibition. This
led the authors to conclude that the impairment of
mitochondrial function was due to a reduced content of
functional complex V [10]. Also, in the sepsis survivors,
complex II-linked respiration increased 2.9-fold from
day 1 to day 7. Our data agree with this latter finding
but stand in contrast to the former, because no inhib-
ition, but rather an increase, of complex II-linked respir-
ation was seen at days 1 to 2. Likely the explanation lies
in the difference between the control cohorts. The mean
respiration value, with complex II-linked substrates, of
PBICs in the critically ill control cohort was approxi-
mately double that of the healthy subjects used in the
present study. In contrast, the same parameter measured
in the sepsis patients was very similar in the two studies.
Because any type of inflammation can trigger mitochon-
drial biogenesis [21], this possibly implies that respiration
was upregulated in the critically ill patients used as con-
trols in the study by Japiassu et al. [10].
In another study examining mitochondrial respiration
in sepsis patients, PBICs, sampled within 48 hours of
ICU admission, were found to have elevated basal respir-
ation, most likely due to a proportional increase in LEAK
respiration, and inhibited complex II-linked respiration as
compared with healthy controls [9]. The difference seen in
respiration in relation to the present study is not entirely
clear but is possibly explained by the fact that we have
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study by Belikova et al. [9], again suggesting a differ-
ence in complex V function. Also we found that freshly
prepared PBICs are prone to aging with consequently
relatively rapid deterioration of mitochondrial respira-
tory function, and a role of the longer incubation time
in the study by Belikova et al. cannot be ruled out.
To be able to put changes in mitochondrial respiratory
function into qualitative and quantitative perspectives, we
chose to analyze three completely different mitochondria-
specific markers. The enzymatic activity of CS is consid-
ered one of the best indicators for mitochondrial matrix
content [22,23]. The level of mtDNA has recently been
shown to correlate with CS [24], and this was confirmed
by our result, in which CS and mtDNA displayed excellent
correlation in both the control cohort and the sepsis pa-
tients (see Figure 2E). The increase in respiration corre-
lated well with the increase of mtDNA number and CS
activity and to a lesser extent with Cyt c. We therefore
chose to relate mitochondrial respiration to the former
two markers. In relation to mtDNA and CS activity, ATP-
generating respiration tended to be lower in the sepsis
patients as compared with controls. This was shown in
a previous study for routine and complex I-linked res-
piration in PBICs, in which respiration was normalized
to protein content [11]. However, as internal quality
control, we demonstrated that control ratios from the
sepsis patients remained higher throughout the time
points measured.
The present data indicate that the initiated process to
enhance mitochondrial capacity results in higher mito-
chondrial numbers per cell, with a net increase in whole-
cell respiration. Within each mitochondrion, there seems
to be a lower increase of some functional units (for
example, complex V), as OXPHOS respiration is less
elevated compared with CS and mtDNA, whereas max-
imal ETS respiration remains constant, in line with recent
findings [10]. However, it is important to stress that over-
all cellular respiration increased in the sepsis population,
and the overall functional integrity of mitochondria in
PBICs was improved, as evidenced by a lower LEAK and
higher control ratios compared with controls at the differ-
ent time points studied.
The failure to induce a biogenesis response at a tran-
scriptional level in muscle biopsies in patients with crit-
ical illness has been associated with worse outcome [12].
Even though our results corroborate the initiation and
execution of events leading to increased mitochondrial
capacity, we could not detect any difference, at any time
point, between survivors and nonsurvivors in mitochon-
drial respiration or the three different markers of mito-
chondrial content measured. The roles of muscle and
PBICs are completely different in sepsis, which could ac-
count for some of the differences seen. Compared withmuscle tissue, PBICs have a much higher turnover, and,
as immune cells, they go from quiescence to activity
during the infectious process and are not subjected to
the passivity usually imposed on muscle tissues in sepsis
patients. The majority of deaths in the present study oc-
curred within the first week, which precludes drawing
any conclusions regarding the change in respiratory cap-
acity for those dying at a later stage. It has been well
established that, in sepsis, a decrease of immune cells
occurs, especially lymphocytes, as a consequence of in-
creased apoptosis [25]. However, as recently described,
concomitant events of both proliferation and apoptosis
are likely present in sepsis [26]. Our results, based on a
defined amount of cells and mitochondria being analyzed,
suggest an intact mitochondrial quality control of the
circulating pool of PBICs.
Posttranslational regulation of the mitochondria is
increasingly recognized as an important modulator of
respiratory capacity. Mitochondria undergo fusion and
fission, whereas upregulated fusion proteins lead to in-
creased respiration [27-29]. Complexes of the ETS, as
well as a majority of the metabolic pathways in the
mitochondria, have been shown to be subjected to regu-
lation by phosphorylation and dephosphorylation [30],
and the electron-transfer complexes are incorporated
into larger assemblies, known as supercomplexes, or
respirasomes, which are proposed to represent the opti-
mal functional units of mitochondrial respiration and
ATP production [31]. The role of these events in regu-
lating the demonstrated increase in mitochondrial res-
piration requires further study.
A limitation of the present study is that it is not pos-
sible to draw conclusions regarding its relevance to
mitochondrial function in other vital organs, such as
liver, kidney, and heart, that are affected in sepsis-
induced MOF. Different cell types have different meta-
bolic requirements and work in a variety of milieus with
various demands on mitochondrial function. Also, as
energy requirement most likely changes during the course
of the sepsis event, we do not know if the enhanced mito-
chondrial respiration observed is adequate for meeting
the metabolic demands, or if a relative energy imbalance
exists in the cells. It is clear that immune cells from
healthy individuals are altered when exposed to infectious
stimuli [32], and this is also reflected in our results. Acti-
vated PBICs have a higher rate of apoptosis, and as the
septic event changes from pro- to antiinflammatory, dif-
ferent subpopulations could be dominant, and this was
not analyzed in the present study.
Further to establish the role of mitochondrial biogenesis,
we attempted to assess the levels of PGC1α, a key regula-
tory protein of mitochondrial biogenesis. However, these
attempts were hindered by the low abundance of the
protein in our samples.
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We demonstrate that, during the first week of sepsis,
cellular respiration of PBICs display an increased cap-
acity because of an increased mitochondrial content but
also with an increased efficacy of the OXPHOS system.
Nonsurvivors displayed the same increase in respiration
as the survivors. The present findings argue against mito-
chondrial respiratory dysfunction, in this type of cell in
sepsis, and it seems clear that mitochondrial function
has to be related to a variety of specific markers to place
results into a relevant context.
Key messages
• Peripheral blood immune cells exhibit increased mitochon-
drial respiratory capacity throughout the course of sepsis.
• The increase in respiratory capacity stems from both an
increase in mitochondrial mass and increased efficacy of
the OXPHOS system.
• No difference in mitochondrial respiratory capacity was
observed between survivors and nonsurvivors.
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